新发DES突变p.Glu401Asp导致严重致心律失常性左心室心肌病/发育不良
在一个西班牙大家系中鉴定出DES基因p.Glu401Asp突变,66名成员中23人为携带者。所有基因阳性者均表现为遗传性致心律失常性心肌病/发育不良表型,病情严重程度不一,心脏不良事件发生率高,无骨骼肌病或传导系统障碍。功能研究提示该突变影响desmin二聚体/寡聚体组装及其与闰盘膜蛋白的连接。
要点
- DES p.Glu401Asp突变可导致以左心室为主的致心律失常性心肌病/发育不良。
- 基因阳性者均出现表型,心脏不良事件发生率高,但无骨骼肌病或传导障碍。
- 致病机制可能涉及desmin组装异常及闰盘膜蛋白连接受损。
核心结论
- DES p.Glu401Asp突变导致以左心室为主的遗传性致心律失常性心肌病/发育不良,心脏不良事件发生率高,无骨骼肌病或传导系统障碍。
研究设计与样本
- 在1个西班牙大家系中鉴定DES p.Glu401Asp突变,对66名家庭成员进行临床和遗传共分离评估。
- 对突变携带者心脏组织进行desmin及闰盘相关蛋白的免疫组化分析。
- 从2名突变携带者和1名非携带者分离间充质干细胞,体外分化为心肌细胞后行实时定量PCR分析。
- 将突变DES基因转染细胞系,用共聚焦显微镜观察。
主要发现
- 66名家庭成员中23人为突变阳性,6人为肯定携带者,2人为可能携带者。
- 免疫组化结果与遗传性致心律失常性心肌病/发育不良相符。
- 功能研究显示突变携带者细胞生长模式和细胞黏附异常,desmin RNA及部分膜蛋白表达降低,转染细胞中突变desmin形成聚集体。
临床怎么用
- 对表现为致心律失常性左心室心肌病/发育不良且无骨骼肌病或传导障碍的患者,应考虑DES基因检测。
- DES p.Glu401Asp突变携带者心脏不良事件发生率高,需密切监测和风险评估。
局限性
- 研究基于单个家系,突变致病机制的普遍性需更多研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Desmin (DES) mutations cause severe skeletal and cardiac muscle disease with heterogeneous phenotypes. Recently, DES mutations were described in patients with inherited arrhythmogenic right ventricular cardiomyopathy/dysplasia, although their cellular and molecular pathomechanisms are not precisely known. Our aim is to describe clinically and functionally the novel DES-p.Glu401Asp mutation as a cause of inherited left ventricular arrhythmogenic cardiomyopathy/dysplasia. METHODS: We identified the novel DES mutation p.Glu401Asp in a large Spanish family with inherited left ventricular arrhythmogenic cardiomyopathy/dysplasia and a high incidence of adverse cardiac events. A full clinical evaluation was performed on all mutation carriers and noncarriers to establish clinical and genetic cosegregation. In addition, desmin, and intercalar disc-related proteins expression were histologically analyzed in explanted cardiac tissue affected by the DES mutation. Furthermore, mesenchymal stem cells were isolated and cultured from 2 family members with the DES mutation (1 with mild and 1 with severe symptomatology) and a member without the mutation (control) and differentiated ex vivo to cardiomyocytes. Then, important genes related to cardiac differentiation and function were analyzed by real-time quantitative polymerase chain reaction. Finally, the p.Glu401Asp mutated DES gene was transfected into cell lines and analyzed by confocal microscopy. RESULTS: Of the 66 family members screened for the DES-p.Glu401Asp mutation, 23 of them were positive, 6 were obligate carriers, and 2 were likely carriers. One hundred percent of genotype-positive patients presented data consistent with inherited arrhythmogenic cardiomyopathy/dysplasia phenotype with variable disease severity expression, high-incidence of sudden cardiac death, and absence of skeletal myopathy or conduction system disorders. Immunohistochemistry was compatible with inherited arrhythmogenic cardiomyopathy/dysplasia, and the functional study showed an abnormal growth pattern and cellular adhesion, reduced desmin RNA expression, and some other membrane proteins, as well, and desmin aggregates in transfected cells expressing the mutant desmin. CONCLUSIONS: The DES-p.Glu401Asp mutation causes predominant inherited left ventricular arrhythmogenic cardiomyopathy/dysplasia with a high incidence of adverse clinical events in the absence of skeletal myopathy or conduction system disorders. The pathogenic mechanism probably corresponds to an alteration in desmin dimer and oligomer assembly and its connection with membrane proteins within the intercalated disc.
引用
- Bermúdez-Jiménez FJ, Carriel V, Brodehl A, et al. Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia. Circulation. 2017. PMID: 29212896. doi:10.1161/CIRCULATIONAHA.117.028719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。